Treatment Patterns And Clinical Outcomes Among Patients in Latin America Receiving First Line Palbociclib Combinations For HR+/HER2- Advanced/Metastatic Breast Cancer In Real World Settings.

Name: Treatment Patterns And Clinical Outcomes Among Patients in Latin America Receiving First Line Palbociclib Combinations For HR+/HER2- Advanced/Metastatic Breast Cancer In Real World Settings.
Published: 2019
License: Public Domain

Pfizer · 2019

ClinicalTrials.gov · Datasets · License: Public Domain · 2019

Open Source ↗

breast cancer metastatic, human epidermal growth factor receptor 2 negative (her2-), hormone receptor positive (hr+), advanced breast cancer (abc), metastatic breast cancer (mbc), observational

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Treatment Patterns And Clinical Outcomes Among Patients in Latin America Receiving First Line Palbociclib Combinations For HR+/HER2- Advanced/Metastatic Breast Cancer In Real World Settings.

Related documents